Epidemiology of Parkinsons disease

Improving economy and health in countries like USA, Germany, has increased the life span and changed the emphasis from communicable to non-communicable diseases. It is expected that the prevalence of Parkinson’s disease in the 7MM (US, France, Italy, Spain, Germany, Brazil, and Japan) and UK will increase from 3.2m people in 2012 to 4.3m people in 2022. The global treatment for syndromes of the movement disorders market is anticipated to grow from an estimated $ 12,859.8 million in 2014 to $ 21,154.8 million in 2020 at a CAGR of 8.6% during the forecast period. This increase the prevalence of age-related diseases and movement disorders like Parkinson's disease (PD). We review epidemiological studies to describe: a) Developments in interdisciplinary of Parkinson and movement disorders, b) Aggregation and Protein Misfolding and c) potential of epidemiological research in countries with multiple ethnic races and environmental risks for PD, d) methodological issues, e) Prevalence of movement disorders.

The Parkinson's disease is the second most typical neurodegenerative disorder, are still mostly unknown. Current thinking is that major gene mutations cause only a small proportion of all cases which in most cases, non-genetic factors play vicinity, in all probability in interaction with susceptibility genes. Various epidemiologic studies have been done to spot such non-genetic risk factors, however most were tiny and methodologically restricted. Larger, well-designed prospective cohort studies have only recently reached a stage at that they need enough incident patients and person-years of follow-up to investigate possible risk factors and their interactions. We have a tendency to review what's familiar regarding the prevalence, incidence, risk factors, and prognosis of Parkinson's disease from epidemiologic studies.

  • Etiology of Parkinsons disease
  • Protein Misfolding & Aggregation
  • Developments in interdisciplinary of Parkinson disease
  • Interdisciplinary care in Parkinsons and other movement disorders

Related Conference of Epidemiology of Parkinsons disease

Aug 02-04, 2017

International Meeting on CNS

Melbourne, Australia
August 29-31, 2017

15th European Neurology Congress

London, UK
August 29-31, 2017

6th World Congress on Addiction Disorder & Addiction Therapy

Prague, Czech Republic
August 31-September 01, 2017

3rdInternational Conference on Epilepsy and Treatment

Brussels, Belgium
September 07-08, 2017

Global Experts Meeting on Brain Disorders

Macau, Hong Kong
November 13-14, 2017

Global Experts Meeting on Neurological Disorders and Stroke

Melbourne, Australia
Oct 12-13, 2017

Internatinal Meeting on Addiction Congress

Osaka, Japan
Oct 12-13, 2017

Global Meeting on Dual Diagnosis and Addiction

Auckland, Newzeland
October 16-17, 2017

17th Global Neuroscience Conference

Osaka, Japan
Nov 13-14, 2017

Gobal Experts Meeting on Neuroscience and Neurochemistry

Melbourne, Australia
February 22-23, 2018

11th International Conference on Vascular Dementia

Paris, France

Epidemiology of Parkinsons disease Conference Speakers